Centiva Capital, LP Cv Rx, Inc. Transaction History

Centiva Capital, LP

$4.79 Billion
Q3 2024

A detailed history of Centiva Capital, LP transactions in Cv Rx, Inc. stock. As of the latest transaction made, Centiva Capital, LP holds 20,176 shares of CVRX stock, worth $285,086. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,176

Holding current value

$285,086

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Nov 14, 2024	BUY	$7.15 - $12.37 $144,258 - $249,577	20,176 New	20,176 $177,000
Q1 2024 May 15, 2024	BUY	$17.99 - $30.49 $214,476 - $363,501	11,922 New	11,922 $217,000

Others Institutions Holding CVRX

# of Institutions

Shares Held

14.4M

Call Options Held

56.3K

Put Options Held

41.8K

Johnson & Johnson New Brunswick, NJ

4.1M
Shares

$58 Million
11.52% of portfolio
Nea Management Company, LLC Timonium, MD

2.37M
Shares

$33.5 Million
1.6% of portfolio
Black Rock Inc. New York, NY

876K
Shares

$12.4 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

824K
Shares

$11.6 Million
0.0% of portfolio
Parkman Healthcare Partners LLC Stamford, CT

683K
Shares

$9.65 Million
0.85% of portfolio

View Full List

About CVRx, Inc.

Ticker CVRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,576,200
Market Cap $291M
Description
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...

More about CVRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.

Account